Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-12-168265
Filing Date
2012-04-18
Accepted
2012-04-18 15:38:01
Documents
3
Period of Report
2012-06-15

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d336720dpre14a.htm PRE 14A 368674
2 GRAPHIC g336720g01c85.jpg GRAPHIC 9088
3 GRAPHIC g336720g22s07.jpg GRAPHIC 244615
  Complete submission text file 0001193125-12-168265.txt   719819
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 12765888
SIC: 2834 Pharmaceutical Preparations